Skip to main content

and
  1. No Access

    Article

    Long-term quality of life after preoperative radiochemotherapy in patients with localized and locally advanced breast cancer

    Preoperative radiotherapy (PRT) or radiochemotherapy (PRCT) is used in different tumor sites. The aim of the study was to examine the long-term quality of life (QoL) of localized / locally advanced breast canc...

    Jan Haussmann, Carolin Nestle-Kraemling, Edwin Bölke in Strahlentherapie und Onkologie (2020)

  2. No Access

    Article

    Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patients

    Preoperative radiotherapy and chemoradiotherapy (PRT/PCRT) represent an increasingly used clinical strategy in different tumor sites. We have previously reported on a PRT/PRCT protocol in patients with locally...

    Christiane Matuschek, Carolin Nestle-Kraemling in Strahlentherapie und Onkologie (2019)

  3. Article

    Open Access

    Retrospective Study of Neoadjuvant Versus Adjuvant Radiochemotherapy in Locally Advanced Noninflammatory Breast Cancer

    This retrospective study compares patients treated between 1991 and 1998 with neoadjuvant radiotherapy ± chemotherapy (RCT) or adjuvant RCT for locally advanced noninflammatory breast cancers (LABC) in terms o...

    Prof. Dr. Stephan Ludwig Roth, Werner Audretsch in Strahlentherapie und Onkologie (2010)

  4. Article

    Open Access

    Predictors of primary breast cancers responsiveness to preoperative Epirubicin/Cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures

    Our goal was to identify gene signatures predictive of response to preoperative systemic chemotherapy (PST) with epirubicin/cyclophosphamide (EC) in patients with primary breast cancer.

    Olga Modlich, Hans-Bernd Prisack, Marc Munnes in Journal of Translational Medicine (2005)

  5. No Access

    Article

    Remission Rates in Breast Cancer Treated with Preoperative Chemotherapy and Radiotherapy

    Evaluation of remission rates after neoadjuvant chemotherapy alone or followed by preoperative radiotherapy.

    Bärbel Gerlach, Werner Audretsch, Frank Gogolin in Strahlentherapie und Onkologie (2003)

  6. Article

    In situ monitoring of early effects of epirubicin-based neoadjuvant chemotherapy in breast cancer by cDNA array technology

    Hans Bojar, Hans Bernd Prisack, Olga Modlich, Mohmoud Danaei in Nature Genetics (2001)

  7. No Access

    Article

    Remission Rates Following Preoperative Chemotherapy and Radiation Therapy in Patients with Breast Cancer

    To evaluate remission and breast-conservation rates after preoperative chemotherapy or chemo-radiotherapy (CT-RT).

    Bärbel Aryus, Werner Audretsch, Frank Gogolin in Strahlentherapie und Onkologie (2000)